p. 230−235
2008-3874
Vol.21/No.3
0.05). In weeks 4 and 12 post-operation, the mean fiber diameters in cell+DMEM group were more than control group (P<0.05). Conclusion: The results of this study demonstrate that transplantation of BMSCs after neurotization surgery, prevent muscle atrophy and improve muscle function.]]>
p. 236−243
2008-3874
Vol.21/No.3
p. 244−252
2008-3874
Vol.21/No.3
p. 253−259
2008-3874
Vol.21/No.3
p. 260−266
2008-3874
Vol.21/No.3
p. 267−276
2008-3874
Vol.21/No.3
p. 277−283
2008-3874
Vol.21/No.3
p. 284−291
2008-3874
Vol.21/No.3
p. 292−300
2008-3874
Vol.21/No.3
p. 301−308
2008-3874
Vol.21/No.3
p. 309−317
2008-3874
Vol.21/No.3
p. 318−324
2008-3874
Vol.21/No.3
0.05 for all patients). Conclusion: Significant correlation between Bax/Bcl-2 ratio determined before radiation therapy and clinical response in the patients, can be used as a biomarker to identify radiosensitive individuals. However, further studies are required to validate radiation-induced apoptotic biomarkers.]]>
p. 325−332
2008-3874
Vol.21/No.3
C, p.A1251P, along with another previously identified mutation (c.1708C>T) in one of the cases. This mutation is located in the MYTH4 protein domain which is a pivotal domain for the myosin function. Another finding in this research was a novel de-novo deletion which deletes the entire EYA1 coding region (EX1-18 DEL). Mutations in EYA1 gene have been found in branchiootorenal (BOR) syndrome. Interestingly the patient with EYA1 deletion did not show any other additional clinical implications apart from HL. This finding might argue for the sole involvement of EYA1 function in the mechanism of hearing. Conclusion: This investigation exhibited that the novel mutations in MYO7A, c.3751G>C, p.A1251P, and EYA1, EX1-18 DEL, were associated with NSHL. Our research increased the mutation spectrum of hearing loss in the Iranian population.]]>
p. 333−341
2008-3874
Vol.21/No.3
p. 342−346
2008-3874
Vol.21/No.3